“Comparison between antineoplastic treatments with selective inhibitors (BRAF/MEK) and the new potentials combinatorial therapies for metastatic melanoma”, RSD, vol. 11, no. 14, p. e326111436275, Oct. 2022, doi: 10.33448/rsd-v11i14.36275.